Columnist Sam Kirton's birthday prompts reflection on his IPF and transplant journey. Like Phil Collins, he says, "Take a look at me now." ...

Suspecting that deconditioning might be contributing to his muscle soreness, columnist Kylene Henderson's husband, Donnie, is ...

Computer-based analyses of CT scans may help predict disease progression and track treatment response among people with PPF, per trial data.

Lower activity of a gene called ZNF331 may help identify obstructive sleep apnea in people with idiopathic pulmonary fibrosis, per a study.

What is Esbriet for idiopathic pulmonary fibrosis? Esbriet (pirfenidone) is an approved oral medication that’s used to slow the decline of lung function in people with idiopathic pulmonary fibrosis ...

What is Ofev for idiopathic pulmonary fibrosis? Ofev (nintedanib) is an approved oral therapy used to treat people with idiopathic pulmonary fibrosis (IPF) and related lung conditions. It is not a ...

Trevi Therapeutics plans to launch two pivotal Phase 3 clinical trials to continue testing Haduvio (nalbuphine extended-release) as a treatment for people with idiopathic pulmonary fibrosis (IPF) who ...

Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...

[vc_row][vc_column][vc_column_text]PRM-151 is a recombinant human serum amyloid P/pentraxin 2 protein developed by Promedior, a biotechnology company developing therapies for fibrotic diseases using ...

Besides medication that can help manage symptoms and slow the progression of pulmonary fibrosis (PF), there are other therapeutic strategies available that can help patients cope with the effects of ...

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.